Report cover image

Global Grass Pollen Allergy Drug Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 95 Pages
SKU # APRC20548212

Description

Summary

According to APO Research, The global Grass Pollen Allergy Drug market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Grass Pollen Allergy Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Grass Pollen Allergy Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Grass Pollen Allergy Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Grass Pollen Allergy Drug include Roxall Medizin GmbH, HAL Allergy BV, Circassia Pharmaceuticals Plc, Biomay AG, Allergy Therapeutics Plc and ALK-Abello A/S, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Grass Pollen Allergy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Grass Pollen Allergy Drug.
The Grass Pollen Allergy Drug market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Grass Pollen Allergy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Grass Pollen Allergy Drug Segment by Company

Roxall Medizin GmbH
HAL Allergy BV
Circassia Pharmaceuticals Plc
Biomay AG
Allergy Therapeutics Plc
ALK-Abello A/S
Grass Pollen Allergy Drug Segment by Type

BM-32
Pollinex Quattro Grass
Others
Grass Pollen Allergy Drug Segment by Application

Hospital
Research Center
Home Use
Grass Pollen Allergy Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Grass Pollen Allergy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Grass Pollen Allergy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Grass Pollen Allergy Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Grass Pollen Allergy Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Grass Pollen Allergy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

95 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Grass Pollen Allergy Drug Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Grass Pollen Allergy Drug Sales Estimates and Forecasts (2020-2031)
1.3 Grass Pollen Allergy Drug Market by Type
1.3.1 BM-32
1.3.2 Pollinex Quattro Grass
1.3.3 Others
1.4 Global Grass Pollen Allergy Drug Market Size by Type
1.4.1 Global Grass Pollen Allergy Drug Market Size Overview by Type (2020-2031)
1.4.2 Global Grass Pollen Allergy Drug Historic Market Size Review by Type (2020-2025)
1.4.3 Global Grass Pollen Allergy Drug Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Grass Pollen Allergy Drug Sales Breakdown by Type (2020-2025)
1.5.2 Europe Grass Pollen Allergy Drug Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Grass Pollen Allergy Drug Sales Breakdown by Type (2020-2025)
1.5.4 South America Grass Pollen Allergy Drug Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Grass Pollen Allergy Drug Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Grass Pollen Allergy Drug Industry Trends
2.2 Grass Pollen Allergy Drug Industry Drivers
2.3 Grass Pollen Allergy Drug Industry Opportunities and Challenges
2.4 Grass Pollen Allergy Drug Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Grass Pollen Allergy Drug Revenue (2020-2025)
3.2 Global Top Players by Grass Pollen Allergy Drug Sales (2020-2025)
3.3 Global Top Players by Grass Pollen Allergy Drug Price (2020-2025)
3.4 Global Grass Pollen Allergy Drug Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Grass Pollen Allergy Drug Major Company Production Sites & Headquarters
3.6 Global Grass Pollen Allergy Drug Company, Product Type & Application
3.7 Global Grass Pollen Allergy Drug Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Grass Pollen Allergy Drug Market CR5 and HHI
3.8.2 Global Top 5 and 10 Grass Pollen Allergy Drug Players Market Share by Revenue in 2024
3.8.3 2023 Grass Pollen Allergy Drug Tier 1, Tier 2, and Tier 3
4 Grass Pollen Allergy Drug Regional Status and Outlook
4.1 Global Grass Pollen Allergy Drug Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Grass Pollen Allergy Drug Historic Market Size by Region
4.2.1 Global Grass Pollen Allergy Drug Sales in Volume by Region (2020-2025)
4.2.2 Global Grass Pollen Allergy Drug Sales in Value by Region (2020-2025)
4.2.3 Global Grass Pollen Allergy Drug Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Grass Pollen Allergy Drug Forecasted Market Size by Region
4.3.1 Global Grass Pollen Allergy Drug Sales in Volume by Region (2026-2031)
4.3.2 Global Grass Pollen Allergy Drug Sales in Value by Region (2026-2031)
4.3.3 Global Grass Pollen Allergy Drug Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Grass Pollen Allergy Drug by Application
5.1 Grass Pollen Allergy Drug Market by Application
5.1.1 Hospital
5.1.2 Research Center
5.1.3 Home Use
5.2 Global Grass Pollen Allergy Drug Market Size by Application
5.2.1 Global Grass Pollen Allergy Drug Market Size Overview by Application (2020-2031)
5.2.2 Global Grass Pollen Allergy Drug Historic Market Size Review by Application (2020-2025)
5.2.3 Global Grass Pollen Allergy Drug Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Grass Pollen Allergy Drug Sales Breakdown by Application (2020-2025)
5.3.2 Europe Grass Pollen Allergy Drug Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Grass Pollen Allergy Drug Sales Breakdown by Application (2020-2025)
5.3.4 South America Grass Pollen Allergy Drug Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Grass Pollen Allergy Drug Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Roxall Medizin GmbH
6.1.1 Roxall Medizin GmbH Comapny Information
6.1.2 Roxall Medizin GmbH Business Overview
6.1.3 Roxall Medizin GmbH Grass Pollen Allergy Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roxall Medizin GmbH Grass Pollen Allergy Drug Product Portfolio
6.1.5 Roxall Medizin GmbH Recent Developments
6.2 HAL Allergy BV
6.2.1 HAL Allergy BV Comapny Information
6.2.2 HAL Allergy BV Business Overview
6.2.3 HAL Allergy BV Grass Pollen Allergy Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 HAL Allergy BV Grass Pollen Allergy Drug Product Portfolio
6.2.5 HAL Allergy BV Recent Developments
6.3 Circassia Pharmaceuticals Plc
6.3.1 Circassia Pharmaceuticals Plc Comapny Information
6.3.2 Circassia Pharmaceuticals Plc Business Overview
6.3.3 Circassia Pharmaceuticals Plc Grass Pollen Allergy Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Circassia Pharmaceuticals Plc Grass Pollen Allergy Drug Product Portfolio
6.3.5 Circassia Pharmaceuticals Plc Recent Developments
6.4 Biomay AG
6.4.1 Biomay AG Comapny Information
6.4.2 Biomay AG Business Overview
6.4.3 Biomay AG Grass Pollen Allergy Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biomay AG Grass Pollen Allergy Drug Product Portfolio
6.4.5 Biomay AG Recent Developments
6.5 Allergy Therapeutics Plc
6.5.1 Allergy Therapeutics Plc Comapny Information
6.5.2 Allergy Therapeutics Plc Business Overview
6.5.3 Allergy Therapeutics Plc Grass Pollen Allergy Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Allergy Therapeutics Plc Grass Pollen Allergy Drug Product Portfolio
6.5.5 Allergy Therapeutics Plc Recent Developments
6.6 ALK-Abello A/S
6.6.1 ALK-Abello A/S Comapny Information
6.6.2 ALK-Abello A/S Business Overview
6.6.3 ALK-Abello A/S Grass Pollen Allergy Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ALK-Abello A/S Grass Pollen Allergy Drug Product Portfolio
6.6.5 ALK-Abello A/S Recent Developments
7 North America by Country
7.1 North America Grass Pollen Allergy Drug Sales by Country
7.1.1 North America Grass Pollen Allergy Drug Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Grass Pollen Allergy Drug Sales by Country (2020-2025)
7.1.3 North America Grass Pollen Allergy Drug Sales Forecast by Country (2026-2031)
7.2 North America Grass Pollen Allergy Drug Market Size by Country
7.2.1 North America Grass Pollen Allergy Drug Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Grass Pollen Allergy Drug Market Size by Country (2020-2025)
7.2.3 North America Grass Pollen Allergy Drug Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Grass Pollen Allergy Drug Sales by Country
8.1.1 Europe Grass Pollen Allergy Drug Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Grass Pollen Allergy Drug Sales by Country (2020-2025)
8.1.3 Europe Grass Pollen Allergy Drug Sales Forecast by Country (2026-2031)
8.2 Europe Grass Pollen Allergy Drug Market Size by Country
8.2.1 Europe Grass Pollen Allergy Drug Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Grass Pollen Allergy Drug Market Size by Country (2020-2025)
8.2.3 Europe Grass Pollen Allergy Drug Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Grass Pollen Allergy Drug Sales by Country
9.1.1 Asia-Pacific Grass Pollen Allergy Drug Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Grass Pollen Allergy Drug Sales by Country (2020-2025)
9.1.3 Asia-Pacific Grass Pollen Allergy Drug Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Grass Pollen Allergy Drug Market Size by Country
9.2.1 Asia-Pacific Grass Pollen Allergy Drug Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Grass Pollen Allergy Drug Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Grass Pollen Allergy Drug Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Grass Pollen Allergy Drug Sales by Country
10.1.1 South America Grass Pollen Allergy Drug Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Grass Pollen Allergy Drug Sales by Country (2020-2025)
10.1.3 South America Grass Pollen Allergy Drug Sales Forecast by Country (2026-2031)
10.2 South America Grass Pollen Allergy Drug Market Size by Country
10.2.1 South America Grass Pollen Allergy Drug Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Grass Pollen Allergy Drug Market Size by Country (2020-2025)
10.2.3 South America Grass Pollen Allergy Drug Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Grass Pollen Allergy Drug Sales by Country
11.1.1 Middle East and Africa Grass Pollen Allergy Drug Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Grass Pollen Allergy Drug Sales by Country (2020-2025)
11.1.3 Middle East and Africa Grass Pollen Allergy Drug Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Grass Pollen Allergy Drug Market Size by Country
11.2.1 Middle East and Africa Grass Pollen Allergy Drug Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Grass Pollen Allergy Drug Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Grass Pollen Allergy Drug Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Grass Pollen Allergy Drug Value Chain Analysis
12.1.1 Grass Pollen Allergy Drug Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Grass Pollen Allergy Drug Production Mode & Process
12.2 Grass Pollen Allergy Drug Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Grass Pollen Allergy Drug Distributors
12.2.3 Grass Pollen Allergy Drug Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us